Tag: Cancer

 The Brooklyn Cancer Center (TBCC), a partnership between New York Cancer & Blood Specialists (NYCBS), one of the leading oncology practices in the nation, and The Brooklyn Hospital Center (TBHC), an independent community hospital in Fort Greene/Downtown Brooklyn, announces it will expand patient access to personalized and advanced radiation treatment at The Brooklyn Hospital Center at 121 DeKalb Ave, Brooklyn, NY 11201. “The Brooklyn Cancer Center will bring the highest level of radiation therapy and advanced treatment options to the Brooklyn community,” said Jeff Vacirca, MD, CEO of NYCBS. Radiation Oncology services will be staffed by dedicated and compassionate radiation ... Read more

 In its 20th year, the Seattle-based nonprofit organization Cancer Pathways decided to be more adventurous in reaching kids and teens affected by cancer. Since 2003, Cancer Pathways’ Camp Sparkle has been held in person at various sites throughout Washington state, including Seattle, Tacoma, Bellevue and Everett. Every year, camp activities lead to campers having fun, making friends with others who understand them, and an opportunity to communicate about the impact of cancer and heal emotionally. This year, the organization wanted to reach more kids throughout Washington state (beyond the four campsites) and connect them with campers living in other states ... Read more

Indian Scientists have recently found that the cancer-causing virus Epstein-Barr Virus (EBV) affects the glial cells or the non-neural cells in the central nervous system and alters molecules like phospho-inositols (PIP); a type of lipid, glycerol, and cholesterol, when the virus infects the brain cells. This could pave the path towards understanding the probable role of the virus in neurodegenerative pathologies, especially given the fact that the virus has been detected in brain tissue of the patients suffering from neurological disorders such as Alzheimer’s, Parkinson and multiple Sclerosis. The EBV can cause cancers like nasopharyngeal carcinoma (a type of head ... Read more

Study explored Mexican patients with advanced cancers; results published in The Oncologist BOSTON – April 26, 2021 – PRLog — Global Cancer Institute (http://globalcancerinstitute.org/) (GCI), which is focused on improving survival rates for underserved cancer patients worldwide, announced today the results of a new study (https://pubmed.ncbi.nlm.nih.gov/33210345/) recently published in The Oncologist on the effectiveness of patient navigation programs for palliative care in Low-and-Middle-Income Countries (LMICs). This research was previously presented in an oral abstract session at the 2019 ASCO Annual Meeting. The study, titled, “Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource-Limited ... Read more

Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States and Canada) announced today an application submission in Japan for the additional indication of Eisai’s in-house discovered and developed multiple receptor tyrosine kinase inhibitor, LENVIMA (generic name: lenvatinib mesylate), in combination with Merck & Co., Inc., Kenilworth, N.J., U.S.A.’s KEYTRUDA (generic name: pembrolizumab) as a treatment for patients with advanced uterine body cancer. This application is based on the results of the pivotal Phase 3 Study 309/KEYNOTE-775 for the treatment of patients with advanced endometrial carcinoma (advanced ... Read more